"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 2018/071893 A1,138-167-724-765-447,2018-04-19,2018,US 2017/0056745 W,2017-10-16,US 201662408490 P,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/138-167-724-765-447,Patent Application,yes,21,2,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K31/395;;A61P25/00;;A61P29/00;;C07D207/263,,16,10,087-843-267-566-970;;013-922-410-051-170;;081-359-493-284-709;;042-613-173-044-999;;016-035-360-844-524;;064-836-925-055-305;;097-730-007-005-116;;077-058-844-932-138;;007-871-832-644-393;;032-145-917-386-792,10.1089/neu.2008.0710;;pmc2800819;;19388818;;10.1080/09638280801923607;;18608429;;10.1038/sj.sc.3100365;;9044512;;10.3171/spi.2002.97.2.0193;;12296678;;10.1016/0304-3959(80)90079-2;;7402693;;10.1038/sj.sc.3101116;;11402361;;10.1080/01952307.1986.11719622;;3783152;;3389794;;10.1159/000099961;;10.1007/bf01420297;;8738385;;9711710;;10.1159/000099917,"HOOK, MA ET AL.: ""Intrathecal Morphine Attenuates Recovery of Function after a Spinal Cord Injury"", JOURNAL OF NEUROTRAMA, May 2009 (2009-05-01), pages 742, XP055476339;;DRYSDALE, DG ET AL.: ""Phantom sensations in people with complete spinal cord lesions: A grounded theory perspective"", DISABILITY AND REHABILITATION, 2009, pages 667, XP055476752;;SIDDALL, PJ ET AL.: ""Classification of pain following spinal cord injury"", SPINAL CORD, 1997, pages 72, XP055476754;;FALCI, SP ET AL.: ""Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome"", JOURNAL OF NEUROSURGERY, September 2002 (2002-09-01), pages 193, XP008098883;;DAVIS ET AL., CLIN ORTHOP, vol. 112, 1975, pages 76 - 80;;RICHARDS ET AL., PAIN, vol. 8, 1980, pages 355 - 366;;SIDDALL ET AL., SPINAL CORD, vol. 39, 2001, pages 63 - 73;;STORMER ET AL., SPINAL CORD, 1997, pages 446 - 455;;WOOLSEY, J AM PARAPLEGIA, vol. 9, 1986, pages 39 - 41;;FRIEDMAN ET AL., J NEUROSURG, vol. 65, 1986, pages 465 - 469;;ISHIJIMA ET AL., APPL NEUROPHYSIOL, vol. 51, no. 2-5, 1988, pages 175 - 187;;RATH ET AL., ACTA NEUROCHIR, vol. 138, no. 4, 1996, pages 364 - 369;;RATH ET AL., STEROTACT FUNCT NEUROSURG, vol. 68, no. 1-4, 1997, pages 161 - 167;;FINNERUP ET AL., SCANDINAVIAN JOURNAL OF PAIN, vol. 1, no. S1, 2009, pages S3 - S11;;FALCI SBEST LBAYLES RLAMMERTSE DSTARNES C, J NEUROSURG SPINE, vol. 97, 2002, pages 193 - 2000;;See also references of EP 3525782A4",PENDING
2,EP,A4,EP 1531897 A4,122-042-037-146-046,2008-12-31,2008,EP 03742149 A,2003-06-25,US 0319766 W;;US 39239602 P;;US 23290802 A,2002-06-27,METHOD FOR ERADICATING PAIN OF CENTRAL ORIGIN RESULTING FROM SPINAL CORD INJURY,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/122-042-037-146-046,Search Report,no,1,0,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61N1/08;;A61B5/04,,2,2,042-613-173-044-999;;008-114-566-811-184,10.3171/spi.2002.97.2.0193;;12296678;;11166482;;10.1016/s0304-3959(00)00369-9,"FALCI SCOTT ET AL: ""Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome."", JOURNAL OF NEUROSURGERY SEP 2002, vol. 97, no. 2 Suppl, September 2002 (2002-09-01), pages 193 - 200, XP008098883, ISSN: 0022-3085;;DEFRIN R ET AL: ""Characterization of chronic pain and somatosensory function in spinal cord injury subjects."", PAIN JAN 2001, vol. 89, no. 2-3, January 2001 (2001-01-01), pages 253 - 263, XP002505049, ISSN: 0304-3959",DISCONTINUED
3,CN,A,CN 110049763 A,144-092-350-531-884,2019-07-23,2019,CN 201780071825 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,CNS BIOSCIENCES INC,FALCI SCOTT P,,https://lens.org/144-092-350-531-884,Patent Application,no,2,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K31/395;;A61P25/00;;A61P29/00;;C07D207/263,,1,0,,,"NB FINNERUP 等: ""Levetiracetam in spinal cord injury pain: a randomized controlled trial"", 《SPINAL CORD》",PENDING
4,AU,A1,AU 2017/341927 A1,043-893-708-782-206,2019-05-30,2019,AU 2017/341927 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,Treating neuropathic pain in spinal cord injured individuals,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,CNS BIOSCIENCES INC,FALCI SCOTT P,"CNS BIOSCIENCES, INC. (2019-06-13)",https://lens.org/043-893-708-782-206,Patent Application,no,0,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,C07D207/263;;A61K31/395;;A61K31/4015;;A61P25/00;;A61P29/00,,0,0,,,,ACTIVE
5,WO,A1,WO 2011/116096 A1,194-639-790-034-312,2011-09-22,2011,US 2011/0028669 W,2011-03-16,US 31440410 P,2010-03-16,METHOD AND DEVICE FOR TENTING DURA MATER IN SPINAL SURGERY,"Disclosed herein is a method, device, and kit for tenting dura mater. In one embodiment, the device is implanted to elevate the dura mater above the spinal cord to prevent or reduce scar tissue. The kit can include a dura mater tenting device and instructions for elevating a dura mater surface above the spinal cord.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/194-639-790-034-312,Patent Application,yes,6,1,1,1,0,A61B17/70,A61B19/00,,0,0,,,,PENDING
6,US,A1,US 2004/0006376 A1,150-202-516-013-107,2004-01-08,2004,US 23290802 A,2002-08-30,US 23290802 A;;US 39239602 P,2002-06-27,Method for eradicating pain of central origin resulting from spinal cord injury,"
   Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury. 
",FALCI SCOTT P.,FALCI SCOTT P,,https://lens.org/150-202-516-013-107,Patent Application,yes,10,36,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04,607/46,0,0,,,,EXPIRED
7,US,B2,US 8502017 B2,166-493-213-428-253,2013-08-06,2013,US 54175409 A,2009-08-14,US 54175409 A;;US 8897808 P,2008-08-14,Rodent model of central neuropathic pain,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/166-493-213-428-253,Granted Patent,yes,4,2,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/033;;G01N33/00,800/14;;800/3,67,62,080-628-440-184-41X;;021-280-270-274-222;;014-891-143-457-324;;000-738-239-138-804;;005-745-267-750-707;;033-873-177-066-313;;068-902-545-636-173;;016-656-176-652-794;;070-603-099-226-140;;061-646-924-469-331;;116-318-125-273-464;;023-554-382-126-118;;087-943-078-916-589;;043-689-947-194-657;;095-890-469-018-931;;117-500-612-945-990;;021-331-094-173-787;;074-267-933-691-112;;004-692-114-452-212;;011-339-592-742-691;;125-004-350-467-315;;042-613-173-044-999;;075-511-141-843-753;;020-981-969-945-988;;005-098-179-702-715;;025-950-485-562-817;;021-781-118-412-032;;049-195-529-310-385;;101-971-217-032-390;;010-604-262-556-78X;;130-476-086-157-583;;072-858-734-080-230;;026-446-005-256-030;;069-799-820-449-852;;091-141-674-770-82X;;059-797-029-150-398;;039-400-910-167-001;;118-965-877-312-802;;116-458-513-425-292;;010-328-533-480-038;;036-902-549-315-632;;012-683-199-860-893;;022-957-551-520-088;;040-195-458-571-782;;020-313-327-245-329;;006-879-071-891-516;;005-912-082-145-645;;059-140-382-107-917;;036-662-587-123-543;;028-088-796-479-024;;135-874-356-576-581;;003-720-522-569-486;;103-562-346-888-131;;063-115-160-520-976;;074-889-742-251-735;;051-037-333-921-019;;055-680-742-711-942;;028-574-127-014-493;;007-478-560-973-095;;015-023-355-776-112;;132-011-327-703-964;;048-908-164-670-45X,pmc6730209;;15574730;;10.1523/jneurosci.3337-04.2004;;14556943;;10.1016/s0006-8993(03)03365-1;;10.1016/s0304-3959(97)00216-9;;9539683;;10.1093/brain/114.3.1381;;2065256;;17329433;;pmc6673468;;10.1523/jneurosci.0138-07.2007;;10.1007/s11068-009-9040-4;;19238548;;11166985;;10.1016/s0304-3959(00)00402-4;;10.1016/s0306-4522(01)00134-8;;11440816;;18484790;;10.2165/00023210-200822060-00002;;10.1089/neu.1995.12.1;;7783230;;10.1007/s00702-005-0300-x;;15868394;;9583755;;10.1016/s0304-3959(97)00220-0;;10.1016/j.expneurol.2006.11.003;;17187780;;pmc2756497;;10.1016/s0002-9610(32)91133-7;;18820413;;10.1016/s0304-3959(01)00354-2;;11731060;;10.1097/nen.0b013e31819344a9;;19104442;;pmc1561531;;16643674;;10.1186/jbiol35;;9429259;;10.1038/sj.sc.3100501;;15393339;;10.3171/jns.1949.6.6.0530;;10.1097/00002517-199302000-00009;;8439716;;10.3171/spi.2002.97.2.0193;;12296678;;14622821;;10.1054/jpai.2001.22788;;10.1089/0897715041650999;;15318998;;pmc3005301;;19332108;;10.1016/j.neuroscience.2009.03.055;;10.1016/s0306-4522(02)00729-7;;12617951;;10.1016/0304-3959(88)90026-7;;3340425;;20779968;;pmc2457248;;10.1136/bmj.2.3941.112;;10.3758/bf03201438;;19883682;;10.1016/j.neubiorev.2009.10.011;;10.1089/neu.2000.17.1205;;11186233;;10.1124/jpet.103.064741;;15007101;;10.1016/0076-6879(90)85043-n;;2381329;;10.1007/s00221-006-0511-x;;16718433;;10.1016/0304-3959(79)90123-4;;460928;;17115910;;10.1089/neu.2006.23.1632;;10.1016/s0304-3959(96)03140-5;;9121808;;7580659;;pmc2551361;;10.1136/bmj.311.7012.1047;;11306633;;pmc6762530;;10.1523/jneurosci.21-08-02808.2001;;12574433;;pmc6741915;;10.1523/jneurosci.23-03-01026.2003;;10.1016/s0006-8993(00)02050-3;;10751570;;10.1097/00006123-198412000-00030;;10.1227/00006123-198412000-00030;;6096761;;10.1089/neu.2008.0661;;19331524;;10.1089/neu.2008-0661;;19049875;;10.1016/j.nbd.2008.10.017;;19103252;;10.1016/j.neulet.2008.12.017;;10.1097/00004691-199301000-00002;;8458993;;10.1016/s0304-3959(02)00452-9;;12791431;;10.1038/sc.2008.136;;19002150;;18808868;;10.1016/s0072-9752(06)80050-3;;11879797;;10.1016/s0006-8993(01)03408-4;;15501197;;10.1016/j.jpain.2004.06.006;;19183259;;10.1111/j.1471-4159.2009.05902.x;;10.1016/0304-3959(96)03116-8;;8895248;;pmc6671613;;10.1523/jneurosci.3142-08.2008;;19052208;;8684613;;10.1016/0306-4522(95)00537-4;;10.1016/s0304-3959(00)00463-2;;11113287;;10.1089/neu.2010.1311;;pmc2966849;;20649467;;10.1016/s0072-9752(06)80025-4;;18808843;;10.1159/000087657;;16215301;;10.1016/s0306-4522(02)00417-7;;12421606;;10.1523/jneurosci.1526-05.2005;;pmc6725303;;16093381;;10.1016/s0006-8993(03)03007-5;;12915254,"Ramer et al., 2004, The Journal of Neuroscience, 24: 10796-10805.;;Aoki et al., 2003, Brain Research, 989: 214-220.;;Yezierski et al., ""Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model,"" Pain 75, 1998, 141-155.;;Yokota et al., ""Sympathetic skin response in patients with multiple sclerosis compared with patients with spinal cord transection and normal controls,"" Brain 114, 1991, 1381-1394.;;Zhao et al., ""Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury,"" J. Neurosci. 27, 2007, 2357-2368.;;Zhou et al., ""Differences in c-jun and nNOS expression levels in motoneurons following different kinds of axonal injury in adult rats,"" Brain Cell Biol. 36, 2008, 213-227.;;PCT International Search Report and Written Opinion dated Oct. 6, 2009, PCT/US2009/053915, 25 pages.;;Abraham et al., ""Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury,"" Pain 90, 2001a, 181-190.;;Abraham, ""The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury,"" Neuroscience 104, 2001b, 863-874.;;Baastrup et al., ""Pharmacological management of neuropathic pain following spinal cord injury,"" CNS Drugs 22, 2008, 455-475.;;Basso et al., ""A sensitive and reliable locomotor rating scale for open field testing in rats,"" J. Neurotrauma 12, 1995, 1-21.;;Beniczky et al., ""Evidence-based pharmacological treatment of neuropathic pain syndromes,"" J. Neural Transm. 112, 2005, 735-749.;;Berman et al., ""Pain following human brachial plexus injury with spinal cord root avulsion and the effect of surgery,"" Pain 75, 1998, 199-207.;;Bigbee et al., ""At-level neuropathic pain is induced by lumbosacral ventral root avulsion injury and ameliorated by room reimplantation into the spinal cord,"" Exp. Neurol. 204, 2007, 273-282.;;Browder et al., ""Do Sympathetic Nerves Transmit Painful Impulses?,"" The American Journal of Surgery 18, 1932, 100-102.;;Carlstedt, ""Root repair review: basic science background and clinical outcome,"" Restor. Neurol. Neurosci. 26, 2008, 225-241.;;Chacur et al., ""A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats,"" Pain 94, 2001, 231-244.;;Chu et al., ""Implantation of neurotrophic factor-treated sensory nerve graft enhances survival and axonal regeneration of motoneurons after spinal root avulsion,"" J. Neuropathol. Exp. Neurol. 68, 2009, 94-101.;;Davies et al., ""Astrocytes derived from glial-restricted precursors promote spinal cord repair,"" J. Biol. 5, 2006, 7.;;Devivo, ""Causes and costs of spinal cord injury in the United States,"" Spinal Cord 35, 1997, 809-813.;;Echlin, ""Pain Responses on Stimulation of the Lumbar Sympathetic Chain under Local Anesthesia,"" Journal of Neurosurgery, 1949, 530-533.;;Edgar et al., ""Computer-assisted DREZ microcoagulation: posttraumatic spinal deafferentation pain,"" J. Spinal Disord. 6, 1993, 48-56.;;Falci et al., ""Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome,"" J. Neurosurg. 97, 2002, 193-200.;;Gorman, ""Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury,"" J. Pain 2, 2001, 229-240.;;Gwak et al., ""Effect of age at time of spinal cord injury on behavioral outcomes in rat,"" J. Neurotrauma 21, 2004, 983-993.;;Gwak et al., ""Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat,"" Neuroscience 161, 2009, 895-903.;;Hains et al., ""Serotenergic neural precursor cell grafts attentuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat,"" Neuroscience 116, 2003, 1097-1110.;;Hargreaves et al., ""A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia,"" Pain 32, 1988, 77-88.;;Harris, ""The Role of the Sympathetic in Sensory Conduction and Certain Neuralgias,"" British Medical Journal 2, 1936, 112-115.;;Harvey, ""Efficient estimation of sensory thresholds,"" Behav. Res. Methods Inst. Comp. 18, 1986, 623-632.;;Huang et al., ""The mirror-image pain: an unclered phenomenon and its possible mechanism,"" Neurosci. Biobehav. 34, 2010, 528-532.;;Hulsebosch et al., ""Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin,"" J. Neurotrauma 17, 2000, 1205-1217.;;Jones et al., ""Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors mediate development, but not maintenance, of secondary allodynia evoked by first-degree burn in the rat,"" J. Pharmacol. Exp. Ther. 310, 2004, 223-229.;;Keown et al., ""Methods for Introducing DNA into Mammalian Cells,"" Methods in Enzymology 185, 1990, 527-537.;;Lampert et al., ""Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury,"" Exp. Brain Res. 174, 2006, 660-666.;;Lombard et al., ""Deafferentation hypersensitivity in the rat after dorsal rhizotomy: a possible animal mode of chronic pain,"" Pain 6, 2, 1979, 163-174.;;McEwen et al., ""Quantification of locomotor recovery following spinal cord contusion in adult rats,"" J. Neurotrauma 23, 2006, 1632-1653.;;McQuay et al., ""A systematic review of antidepressants in neuropathic pain,"" Pain 68, 1996, 217-227.;;McQuay et al., ""Anticonvulsant drugs for management of pain: a systematic review,"" British Medical Journal 311, 1995, 1047-1052.;;Milligan et al., ""Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines,"" J. Neurosci. 21, 2001, 2808-2819.;;Milligan et al., ""Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats,"" J. Neurosci. 23, 2003, 1026-1040.;;Milligan et al., ""Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120,"" Brain Res. 861, 2000, 105-116.;;Ovelmen-Levitt et al., ""Dorsal root rhizotomy and avulsion in the cat: a comparison of long term effects on dorsal horn neuronal activity,"" Neurosurgery 15, 1984, 921-927.;;Penas et al., ""Cytoskeletal and activity-related changes in spinal motoneurons after root avulsion,"" J. Neurotrauma 26, 2009, 763-779.;;Rodrigues Hell et al., ""Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsion,"" Neurobiol. Dis. 33, 2009, 290-300.;;Scorisa et al., ""Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion,"" Neurosci. Lett. 451, 2009, 34-39.;;Shields, ""Functional Anatomy of the Autonomic Nervous System,"" Journal of Clinical Neurophysiology 10, 1993, 2-13.;;Siddall et al., ""A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury,"" Pain 103, 2003, 249-257.;;Siddall et al., ""Management of neuropathic pain following spinal cord injury: now and in the future,"" Spinal Cord 47, 2009, 352-359.;;Siddall et al., ""Pain following spinal cord injury, in: Handbook of Clinical Neurology,"" F. Cervero and T.S. Jensen (eds), Elsevier: Philadelphia, 2006, 689-703.;;Sorkin et al., ""Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systematically or intrathecally despite its dependence on capsaicin sensitive afferents,"" Brain Res. 930, 2002, 67-74.;;Spataro et al., ""Spinal gap junctions: potential involvement in pain facilitation,"" J. Pain 5, 2004, 392-405.;;Su et al., ""Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor,"" J. Neurochem. 108, 2009, 1385-1398.;;Takahashi et al., ""Dermatomes in the rat limbs as determined by antidromic stimulation of sensory C-fibers in spinal nerves,"" Pain 67, 1996, 197-202.;;Tan et al., ""Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury,"" J. Neurosci. 28, 2008, 13173-13183.;;Thompson et al., ""Leukemia inhibitory factor induces mechanical allodynia but not thermal hyperalgesia in the juvenile rat,"" Neuroscience 71, 1996, 1091-1094.;;Vierck Jr. et al., ""Pain following spinal cord injury: animal models and mechanistic studies,"" Pain 89, 2000, 1-5.;;Wieseler et al., ""Below Level Central Pain Induced by Discrete Dorsal Spinal Cord Injury,"" Journal of Neurotrauma 27, Sep. 2010, 1697-1707.;;Yezierski, ""Pain following spinal cord injury: central mechanisms,"" Handb. Clin. Neurol. 81, 2006, 293-307.;;Yezierski ""Spinal Cord Injury: A Model of Central Neuropathic Pain,"" Neurosignals, 14, 4, Oct. 2005, 182-193.;;Australian Office Action dated Apr. 16, 2012, Australian Patent Application No. 2009281824, 2 pages.;;Felipe, et al., ""Excitotoxic injury to the rat spinal cord does not promote sprouting of myelinated fibers to the superficial laminae,"" Database Biosis [online] Biosciences Information Service, Philadelphia, Pennsylvania, 2003, 3 pages.;;Saade, et al., ""The Role of the Dorsal Columns in Neuropathic Behavior: Evidence for Plasticity and Non-Specificity,"" Neuroscience, 2002, vol. 115, No. 2, pp. 403-413.;;Scholz, et al., ""Blocking Caspase Activity Prevents Transsynaptic Neuronal Apoptosis and the Loss of Inhibition in Lamina II of the Dorsal Horn after Peripheral Nerve Injury,"" The Journal of Neuroscience, Aug. 10, 2005, vol. 25, No. 32, pp. 7317-7323.;;Canadian Office Action dated Oct. 10, 2012, Canadian Application No. 2,733,987, 3 pages.;;Rodrigues-Filho, Avulsion injury of the rat brachial plexus triggers hyperalgesia and allodynia in the hindpaws: a new model for the study of neuropathic pain, Brain Res. (Aug. 29, 2003), 982(2):186-194.;;Non-Final Office Action dated Mar. 4, 2013, U.S. Appl. No. 13/059,027, 10 pages.",INACTIVE
8,CA,A1,CA 2733987 A1,181-524-127-821-342,2010-02-18,2010,CA 2733987 A,2009-08-14,US 8897808 P;;US 2009/0053915 W,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND METHODS OF MAKING AND USING THE SAME,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/181-524-127-821-342,Patent Application,no,0,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00,,0,0,,,,INACTIVE
9,US,B2,US 7130691 B2,079-880-154-207-608,2006-10-31,2006,US 23290802 A,2002-08-30,US 23290802 A;;US 39239602 P,2002-06-27,Method for eradicating pain of central origin resulting from spinal cord injury,"Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/079-880-154-207-608,Granted Patent,yes,10,17,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61N1/18;;A61B5/04,607/46,55,47,004-005-536-543-723;;064-836-925-055-305;;009-676-914-696-09X;;043-689-947-194-657;;034-179-804-649-603;;102-900-691-991-204;;054-194-944-604-950;;111-954-598-624-258;;011-339-592-742-691;;004-005-536-543-723;;033-182-080-390-915;;093-789-739-978-854;;050-404-273-241-374;;049-195-529-310-385;;061-013-964-046-085;;077-058-844-932-138;;045-512-160-146-132;;030-078-041-013-376;;042-464-219-707-289;;078-676-565-842-433;;071-711-773-037-486;;063-117-296-772-848;;146-086-629-932-409;;068-924-012-284-272;;007-786-314-603-595;;007-736-069-997-141;;107-525-322-360-159;;028-569-557-818-604;;071-831-190-849-016;;065-000-261-982-056;;119-631-962-944-712;;007-871-832-644-393;;032-145-917-386-792;;016-035-360-844-524;;052-673-967-040-866;;099-057-983-804-674;;006-879-071-891-516;;064-836-925-055-305;;113-001-920-533-224;;135-874-356-576-581;;009-773-696-078-924;;051-037-333-921-019;;024-882-109-495-624;;097-730-007-005-116;;000-738-239-138-804;;021-631-601-628-577;;075-553-981-780-615,10.1038/sj.sc.3100737;;9773443;;10.1038/sj.sc.3101116;;11402361;;15995126;;10.2106/jbjs.d.02840;;10.1016/s0002-9610(32)91133-7;;10.1016/j.pain.2004.08.010;;15494196;;1192653;;11166964;;10.1016/s0304-3959(00)00490-5;;10.1097/00004691-199701000-00003;;9013358;;15393339;;10.3171/jns.1949.6.6.0530;;10.1038/sj.sc.3100737;;9773443;;20270305;;10.1001/archsurg.1947.01230080441005;;3760955;;10.3171/jns.1986.65.4.0465;;10.1093/brain/awh623;;16109750;;20779968;;pmc2457248;;10.1136/bmj.2.3941.112;;10.1126/science.1094925;;15131310;;3389794;;10.1159/000099961;;10.2174/1568010043343804;;15379598;;10.1016/j.expneurol.2005.02.019;;15899262;;10.1159/000100133;;3490223;;15389827;;10.1002/jnr.20274;;15233942;;10.1016/j.ymthe.2004.04.017;;15256650;;10.1126/science.305.5682.326;;10.1016/0304-3959(77)90133-6;;15879185;;10.1126/science.308.5723.778;;15350966;;10.1016/j.nbd.2004.05.010;;448420;;10.3171/jns.1979.51.1.0059;;10.3171/jns.1981.55.3.0414;;6167696;;16219025;;10.1111/j.1471-4159.2005.03462.x;;9521323;;10.1038/32660;;10911921;;10.1111/j.1749-6632.2000.tb06673.x;;15338057;;10.1007/s00018-004-4235-4;;10.1007/bf01420297;;8738385;;9711710;;10.1159/000099917;;10.1016/0304-3959(80)90079-2;;7402693;;10.2174/1568026054367638;;16022678;;10.1152/jn.1997.78.5.2641;;9356413;;10.1097/00004691-199301000-00002;;8458993;;10.1038/sj.sc.3101116;;11402361;;15960884;;10.1111/j.1745-7254.2005.00123.x;;15501197;;10.1016/j.jpain.2004.06.006;;9232750;;10.1038/sj.sc.3100411;;10.1016/s0304-3959(00)00463-2;;11113287;;10.1159/000087655;;16215299;;10.1080/01952307.1986.11719622;;3783152;;10.1093/brain/114.3.1381;;2065256;;10.1016/j.molbrainres.2005.04.013;;15922485;;9121805;;10.1016/s0304-3959(96)03178-8,"Nashold, Jr., Blaine S., Ostdahl, Roger H., Bullitt, Elizabeth, Friedman, Allan, and Brophy, Brian, ""Dorsal Root Entry Zone Lesions: A New Neurosurgical Theraphy for Deafferentation Pain"", Advances in Pain Research and Therapy, 1983, vol. 5, pp. 739-750.;;Eide, P.K., ""Pathophysiological Mechanisms of Central Neuropathic Pain After Spinal Cord Injury"", Scientific Review 1998, 36, 601-612.;;Siddall, P.J., Loeser, J.D., ""Pain Following Spinal Cord Injury"", Scientific Review 2001, 39, 63-73.;;Alpantaki, et al., ""Sympathetic and Sensory Neural Elements in the Tendon of the Long Head of the Biceps,"" The Journal of Bone and Joint Surgery, Jul. 2005, pp. 1580-1583, vol. 87-A, No. 7.;;Browder, ""Do Sympathetic Nerves Transmit Painful Impulses?"", The American Journal of Surgery, 1932, pp. 100-102, vol. 18, No. 1.;;Cronin, et al., ""Laminar distribution of GABA<SUB>A</SUB>-and glycine-receptor mediated tonic inhibition in the dorsal hom of the rat lumbar spinal cord: effects of picrotoxin and strychnine on expression of Fos-like immunoreactivity,"" Pain, Nov. 2004, pp. 156-163, vol. 112.;;Davis, ""Pain and Suffering Following Spinal Cord Injury,"" Clinical Orthopaedics and Related Research, 1975, pp. 76-80, No. 112.;;DeLeo, et al., ""The role of neuroinflammation and neuroimmune activation in persistent pain,"" Pain, 2001, pp. 1-6, vol. 90.;;Deutscher [editor], Methods in Enzymology, 1990, vol. 182: Guide to Protein Purification, Academic Press, Inc.;;Dotson, Clinical Neurophysiology Laboratory Tests to assess the Nociceptive System in Humans, Journal of Clinical Neurophysiology, 1997, pp. 32-45, vol. 14, No. 1.;;Echlin, ""Pain Responses on Stimulation of the Lumbar Sympathetic Chain under Local Anesthesia,"" Journal of Neurosurgery, 1949, pp. 530-533, vol. 6.;;Eide, ""Pathophysiological mechanisms of central neuropathic pain after spinal cord injury,"" Spinal Cord, 1998, pp. 601-612, vol. 36, No. 9.;;Freeman, et al., ""Surgical Relief of Pain in Paraplegic Patients,"" Archives of Surgery, 1947, pp. 433-440, vol. 55.;;Friedman et al., ""DREZ lesions for relief of pain related to spinal cord injury,"" Journal of Neurosurgery, 1986, pp. 465-469, vol. 65, No. 4.;;Goeddel [editor], Methods in Enzymology, 1990, vol. 185: Gene Expression Technology, Academic Press, Inc.;;Graham, et al., ""Chapter 11: Manipulation of Adenoviris Vectors,"" Methods in Molecular Biology, 1991, pp. 109-128, vol. 7: Gene Transfer and Expression Protocols, The Humana Press Inc., Clifton, New Jersey.;;Hains, et al., ""Changes in electrophysiological properties and sodium channel Na<SUB>v</SUB>1.3 expression in thalamic neurons after spinal cord injury,"" Brain, 2005, pp. 2359-2371, vol. 128.;;Harris, ""The Role of the Sympathetic in Sensory Conduction and Certain Neuralgias,"" British Medical Journal, 1936, pp. 112-115, vol. 2.;;Harvey, et al., ""GlyR alpha3: An Essential Target for Spinal PGE<SUB>2</SUB>-Mediated Inflammatory Pain Sensitization,"" Science, 2004, pp. 884-887, vol. 304.;;Human, ""Research knocks out pain,"" Denver Post, 2005.;;Innis, et al., [editor], PCR Protocols: A Guide to Methods and Applications , 1990, Academic Press, Inc., San Diego, California.;;Ishijima, et al., ""Lesions of Spinal and Trigeminal Dorsal Root Entry Zone for Deafferentation Pain,"" Applied Neurophysiology, 1988, pp. 175-187, vol. 51, No. 2-5.;;Ji, ""Peripheral and Central Mechanisms of Inflammatory Pain, with Emphasis on MAP Kinases,"" Current Drug Targets -Inflammation & Allergy, 2004, pp. 299-303, vol. 3, No. 3.;;Jongen, et al., ""Intrathecal injection of GDNF and BDNF induces immediate early gene expression in rat spinal dorsal horn,"" Experimental Neurology, Jul. 2005, pp. 255-266, vol. 194, No. 1.;;Katims, et al. ""Transcutaneous Nerve Stimulation,"" Applied Neurophysiology, 1986, pp. 86-91, vol. 49, No. 1-2.;;Li, et al., ""Alterations in Spinal Cord Gene Expression After Hindpaw Formalin Injection,"" Journal of Neuroscience Research, 2004, pp. 533-541, vol. 78.;;Liu, et al., ""Peripherally Delivered Glutamic Acid Decarboxylase Gene Therapy for Spinal Cord Injury Pain,"" Molecular Therapy, 2004 pp. 57-66, vol. 10, No. 1.;;Marx, ""Prolonging the Agony,"" Science, 2004, pp. 326-329, vol. 305.;;Melzack, et al., ""Phantom Body Pain in Paraplegics: Evidence for a Central 'Pattern Generating Mechanism' for Pain,"" Pain, 1978, pp. 195-210, vol. 4.;;Miller, ""The Dark Side of Glia"" Science, 2005, pp. 778-781, vol. 308.;;Morales-Aza, et al., ""Inflammation alters cation chloride cotransporter expression in sensory neurons,"" Neurobiology of Disease, 2004, pp. 62-69, vol. 17.;;Nashold Jr., et al., ""Dorsal root entry zone lesions for pain relief,"" Journal of Neurosurgery, 1979, pp. 59-69, vol. 51, Nos. 1-6.;;Nashold Jr., et al., ""Dorsal root entry zone lesions to control central pain in paraplegics,"" Journal of Neurosurgery, 1981, pp. 414-419, vol. 55, Nos. 1-6.;;Nesic, et al., ""Transcriptional profiling of spinal cord injury-induced central neuropathic pain,"" Journal of Neurochemistry, 2005, pp. 998-1014, vol. 95.;;Okuda-Ashitaka, et al., ""Nocistatin, a peptide that blocks nociceptin action in pain transmission,"" Nature, 1998, pp. 286-289, vol. 392, No. 6673.;;Ossipov, et al., ""Spinal and Supraspinal Mechanisms of Neuropathic Pain,"" Annals of the New York Academy of Sciences, 2000, pp. 12-24, vol. 909.;;Patte-Mensah, et al., ""Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks,"" Cellular and Molecular Life Sciences, Sep. 2004, pp. 2274-2284, vol. 61, No. 17.;;Pick, The Autonomic Nervous System, 1970, J.B. Lippincott Company, U.S.;;Rath, et al., ""Results of DREZ Coagulations for Pain Related to Plexus Lesions, Spinal Cord Injuries and Postherpetic Neuralgia,"" Acta Neurochirurgica, 1996, pp. 364-369, vol. 138, No. 4.;;Rath, et al., ""DREZ Coagulations for Deafferentation Pain Related to Spinal and Peripheral Nerve Lesions: Indication and Results of 79 Consecutive Procedures,"" Stereotactic and Functional Neurosurgery, 1997, pp. 161-167, vol. 68.;;Richards, et al., ""Psycho-Social Aspects of Chronic Pain in Spinal Cord Injury,"" Pain, 1980, pp. 355-366, vol. 8.;;Salter, ""Cellular Signalling Pathways of Spinal Pain Neuroplasticity as Targets for Analgesic Development,"" Current Topics in Medicinal Chemistry, 2005, pp. 557-567, vol. 5, No. 6.;;Sambrook, et al., Molecular Cloning, 1989, Cold Spring Harbor Laboratory Press, U.S.;;Schmidt, et al., ""Innervation Territories of Mechanically Activated C Nociceptor Units in Human Skin,"" Journal of Neurophysiology, 1997, pp. 2641-2648,vol. 78, No. 5.;;Shields, ""Functional Anatomy of the Autonomic Nervous System,"" Journal of Clinical Neurophysiology, 1993, pp. 2-13, vol. 10, No. 1.;;Siddal, et al., ""Pain following spinal cord injury,"" Spinal Cord, 2001, pp. 63-73, vol. 39, No. 2.;;Song, et al., ""Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats,"" Acta Pharmacologica Sinica, Jul. 2005, pp. 789-798, vol. 26, No. 7.;;Spataro, et al., ""Spinal Gap Junctions: Potential Involvement in Pain Facilitation,"" The Journal of Pain, Sep. 2004, pp. 392-405, vol. 5, No. 7.;;Störmer, et al., ""Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study,"" Spinal Cord, 1997, pp. 446-455, vol. 35, No. 7.;;Vierck Jr., et al., ""Pain following spinal cord injury: animal models and mechanistic studies,"" Pain, 2000, pp. 1-5, vol. 89.;;Wieseler-Frank, et al., ""Central Proinflammatory Cytokines and Pain Enhancement,"" Neurosignals, 2005, pp. 166-174, vol. 14.;;Woolsey, ""Chronic Pain Following Spinal Cord Injury,"" The Joural of the American Paraplegia Society, 1986, pp. 39-41, vol. 9.;;Yokota, et al., ""Sympathetic Skin Response in Patients with Multiple Sclerosis Compared with Patients with Spinal Cord Transection and Normal Controls,"" Brain, 1991, pp. 1381-1394, vol. 114, No. 3.;;Yu, et al., ""Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury,"" Molecular Brain Research, 2005, pp. 244-255, vol. 138.;;Yezierski, ""Pain following spinal cord injury: the clinical problem and experimental studies,"" Pain, 1996, pp. 185-194, vol. 68, Nos. 2-3.",EXPIRED
10,CA,C,CA 2733987 C,106-245-569-164-915,2016-06-14,2016,CA 2733987 A,2009-08-14,US 8897808 P;;US 2009/0053915 W,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND METHODS OF MAKING AND USING THE SAME,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/106-245-569-164-915,Granted Patent,no,0,0,14,14,0,A01K67/027;;A01K2207/30;;A01K2227/105;;A01K2267/0393;;G01N33/5088;;A61K49/0008;;A61K9/0085;;A01K67/027;;A01K2207/30;;A01K2227/105;;A01K2267/0393;;G01N33/5088;;A61K49/0008,C12Q1/00;;A01K67/027;;A61K45/00,,0,0,,,,INACTIVE
11,US,B2,US 9452226 B2,061-593-488-071-434,2016-09-27,2016,US 201313960465 A,2013-08-06,US 201313960465 A;;US 54175409 A;;US 8897808 P,2008-08-14,Rodent model of central neuropathic pain caused by dorsal root entry zone avulsion at T13,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/061-593-488-071-434,Granted Patent,yes,6,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/033;;A01K67/027;;A61K9/00;;A61K49/00;;G01N33/50,,67,62,068-902-545-636-173;;016-656-176-652-794;;070-603-099-226-140;;061-646-924-469-331;;116-318-125-273-464;;023-554-382-126-118;;087-943-078-916-589;;043-689-947-194-657;;095-890-469-018-931;;117-500-612-945-990;;021-331-094-173-787;;074-267-933-691-112;;004-692-114-452-212;;011-339-592-742-691;;125-004-350-467-315;;042-613-173-044-999;;075-511-141-843-753;;020-981-969-945-988;;005-098-179-702-715;;025-950-485-562-817;;021-781-118-412-032;;049-195-529-310-385;;101-971-217-032-390;;010-604-262-556-78X;;130-476-086-157-583;;072-858-734-080-230;;026-446-005-256-030;;069-799-820-449-852;;091-141-674-770-82X;;059-797-029-150-398;;039-400-910-167-001;;118-965-877-312-802;;116-458-513-425-292;;010-328-533-480-038;;036-902-549-315-632;;012-683-199-860-893;;022-957-551-520-088;;040-195-458-571-782;;020-313-327-245-329;;006-879-071-891-516;;005-912-082-145-645;;059-140-382-107-917;;036-662-587-123-543;;028-088-796-479-024;;135-874-356-576-581;;003-720-522-569-486;;103-562-346-888-131;;063-115-160-520-976;;074-889-742-251-735;;051-037-333-921-019;;055-680-742-711-942;;028-574-127-014-493;;007-478-560-973-095;;014-891-143-457-324;;000-738-239-138-804;;005-745-267-750-707;;033-873-177-066-313;;048-908-164-670-45X;;015-023-355-776-112;;132-011-327-703-964;;080-628-440-184-41X;;021-280-270-274-222,11166985;;10.1016/s0304-3959(00)00402-4;;10.1016/s0306-4522(01)00134-8;;11440816;;18484790;;10.2165/00023210-200822060-00002;;10.1089/neu.1995.12.1;;7783230;;10.1007/s00702-005-0300-x;;15868394;;9583755;;10.1016/s0304-3959(97)00220-0;;10.1016/j.expneurol.2006.11.003;;17187780;;pmc2756497;;10.1016/s0002-9610(32)91133-7;;18820413;;10.1016/s0304-3959(01)00354-2;;11731060;;10.1097/nen.0b013e31819344a9;;19104442;;pmc1561531;;16643674;;10.1186/jbiol35;;9429259;;10.1038/sj.sc.3100501;;15393339;;10.3171/jns.1949.6.6.0530;;10.1097/00002517-199302000-00009;;8439716;;10.3171/spi.2002.97.2.0193;;12296678;;14622821;;10.1054/jpai.2001.22788;;10.1089/0897715041650999;;15318998;;pmc3005301;;19332108;;10.1016/j.neuroscience.2009.03.055;;10.1016/s0306-4522(02)00729-7;;12617951;;10.1016/0304-3959(88)90026-7;;3340425;;20779968;;pmc2457248;;10.1136/bmj.2.3941.112;;10.3758/bf03201438;;19883682;;10.1016/j.neubiorev.2009.10.011;;10.1089/neu.2000.17.1205;;11186233;;10.1124/jpet.103.064741;;15007101;;10.1016/0076-6879(90)85043-n;;2381329;;10.1007/s00221-006-0511-x;;16718433;;10.1016/0304-3959(79)90123-4;;460928;;17115910;;10.1089/neu.2006.23.1632;;10.1016/s0304-3959(96)03140-5;;9121808;;7580659;;pmc2551361;;10.1136/bmj.311.7012.1047;;11306633;;pmc6762530;;10.1523/jneurosci.21-08-02808.2001;;12574433;;pmc6741915;;10.1523/jneurosci.23-03-01026.2003;;10.1016/s0006-8993(00)02050-3;;10751570;;10.1097/00006123-198412000-00030;;10.1227/00006123-198412000-00030;;6096761;;10.1089/neu.2008.0661;;19331524;;10.1089/neu.2008-0661;;19049875;;10.1016/j.nbd.2008.10.017;;19103252;;10.1016/j.neulet.2008.12.017;;10.1097/00004691-199301000-00002;;8458993;;10.1016/s0304-3959(02)00452-9;;12791431;;10.1038/sc.2008.136;;19002150;;18808868;;10.1016/s0072-9752(06)80050-3;;11879797;;10.1016/s0006-8993(01)03408-4;;15501197;;10.1016/j.jpain.2004.06.006;;19183259;;10.1111/j.1471-4159.2009.05902.x;;10.1016/0304-3959(96)03116-8;;8895248;;pmc6671613;;10.1523/jneurosci.3142-08.2008;;19052208;;8684613;;10.1016/0306-4522(95)00537-4;;10.1016/s0304-3959(00)00463-2;;11113287;;10.1089/neu.2010.1311;;pmc2966849;;20649467;;10.1016/s0072-9752(06)80025-4;;18808843;;10.1159/000087657;;16215301;;10.1016/s0304-3959(97)00216-9;;9539683;;10.1093/brain/114.3.1381;;2065256;;17329433;;pmc6673468;;10.1523/jneurosci.0138-07.2007;;10.1007/s11068-009-9040-4;;19238548;;10.1016/s0006-8993(03)03007-5;;12915254;;10.1016/s0306-4522(02)00417-7;;12421606;;10.1523/jneurosci.1526-05.2005;;pmc6725303;;16093381;;pmc6730209;;15574730;;10.1523/jneurosci.3337-04.2004;;14556943;;10.1016/s0006-8993(03)03365-1,"Abraham et al., ""Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury,"" Pain 90, 2001a, 181-190.;;Abraham, ""The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury,"" Neuroscience 104, 2001b, 863-874.;;Baastrup et al., ""Pharmacological management of neuropathic pain following spinal cord injury,"" CNS Drugs 22, 2008, 455-475.;;Basso et al., ""A sensitive and reliable locomotor rating scale for open field testing in rats,"" J. Neurotrauma 12, 1995, 1-21.;;Beniczky et al., ""Evidence-based pharmacological treatment of neuropathic pain syndromes,"" J. Neural Transm. 112, 2005, 735-749.;;Berman et al., ""Pain following human brachial plexus injury with spinal cord root avulsion and the effect of surgery,"" Pain 75, 1998, 199-207.;;Bigbee et al., ""At-level neuropathic pain is induced by lumbosacral ventral root avulsion injury and ameliorated by room reimplantation into the spinal cord,"" Exp. Neurol. 204, 2007, 273-282.;;Browder et al., ""Do Sympathetic Nerves Transmit Painful Impulses?,"" The American Journal of Surgery 18, 1932, 100-102.;;Carlstedt, ""Root repair review: basic science background and clinical outcome,"" Restor. Neurol. Neurosci. 26, 2008, 225-241.;;Chacur et al., ""A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats,"" Pain 94, 2001, 231-244.;;Chu et al., ""Implantation of neurotrophic factor-treated sensory nerve graft enhances survival and axonal regeneration of motoneurons after spinal root avulsion,"" J. Neuropathol. Exp. Neurol. 68, 2009, 94-101.;;Davies et al., ""Astrocytes derived from glial-restricted precursors promote spinal cord repair,"" J. Biol. 5, 2006, 7.;;Devivo, ""Causes and costs of spinal cord injury in the United States,"" Spinal Cord 35, 1997, 809-813.;;Echlin, ""Pain Responses on Stimulation of the Lumbar Sympathetic Chain under Local Anesthesia,"" Journal of Neurosurgery, 1949, 530-533.;;Edgar et al., ""Computer-assisted DREZ microcoagulation: posttraumatic spinal deafferentation pain,"" J. Spinal Disord. 6, 1993, 48-56.;;Falci et al., ""Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome,"" J. Neurosurg. 97, 2002, 193-200.;;Gorman, ""Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury,"" J. Pain 2, 2001, 229-240.;;Gwak et al., ""Effect of age at time of spinal cord injury on behavioral outcomes in rat,"" J. Neurotrauma 21, 2004, 983-993.;;Gwak et al., ""Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat,"" Neuroscience 161, 2009, 895-903.;;Hains et al., ""Serotonergic neural precursor cell grafts attentuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat,"" Neuroscience 116, 2003, 1097-1110.;;Hargreaves et al., ""A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia,"" Pain 32, 1988, 77-88.;;Harris, ""The Role of the Sympathetic in Sensory Conduction and Certain Neuralgias,"" British Medical Journal 2, 1936, 112-115.;;Harvey, ""Efficient estimation of sensory thresholds,"" Behav. Res. Methods Inst. Comp. 18, 1986, 623-632.;;Huang et al., ""The mirror-image pain: an unclered phenomenon and its possible mechanism,"" Neurosci. Biobehav. 34, 2010, 528-532.;;Hulsebosch et al., ""Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin,"" J. Neurotrauma 17, 2000, 1205-1217.;;Jones et al., ""Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors mediate development, but not maintenance, of secondary allodynia evoked by first-degree burn in the rat,"" J. Pharmacol. Exp. Ther. 310, 2004, 223-229.;;Keown et al., ""Methods for Introducing DNA into Mammalian Cells,"" Methods in Enzymology 185, 1990, 527-537.;;Lampert et al., ""Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury,"" Exp. Brain Res. 174, 2006, 660-666.;;Lombard et al., ""Deafferentation hypersensitivity in the rat after dorsal rhizotomy: a possible animal mode of chronic pain,"" Pain 6, 2, 1979, 163-174.;;McEwen et al., ""Quantification of locomotor recovery following spinal cord contusion in adult rats,"" J. Neurotrauma 23, 2006, 1632-1653.;;McQuay et al., ""A systematic review of antidepressants in neuropathic pain,"" Pain 68, 1996, 217-227.;;McQuay et al., ""Anticonvulsant drugs for management of pain: a systematic review,"" British Medical Journal 311, 1995, 1047-1052.;;Milligan et al., ""Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines,"" J. Neurosci. 21, 2001, 2808-2819.;;Milligan et al., ""Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats,"" J. Neurosci. 23, 2003, 1026-1040.;;Milligan et al., ""Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120,"" Brain Res. 861, 2000, 105-116.;;Ovelmen-Levitt et al., ""Dorsal root rhizotomy and avulsion in the cat: a comparison of long term effects on dorsal horn neuronal activity,"" Neurosurgery 15, 1984, 921-927.;;Penas et al., ""Cytoskeletal and activity-related changes in spinal motoneurons after root avulsion,"" J. Neurotrauma 26, 2009, 763-779.;;Rodrigues Hell et al., ""Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsion,"" Neurobiol. Dis. 33, 2009, 290-300.;;Scorisa et al., ""Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion,"" Neurosci. Lett. 451, 2009, 34-39.;;Shields, ""Functional Anatomy of the Autonomic Nervous System,"" Jounal of Clinical Neurophysiology 10, 1993, 2-13.;;Siddall et al., ""A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury,"" Pain 103, 2003, 249-257.;;Siddall et al., ""Management of neuropathic pain following spinal cord injury: now and in the future,"" Spinal Cord 47, 2009, 352-359.;;Siddall et al., ""Pain following spinal cord injury, in: Handbook of Clinical Neurology,"" F. Cervero and T.S. Jensen (eds), Elsevier: Philadelphia, 2006, 689-703.;;Sorkin et al., ""Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systematically or intrathecally despite its dependence on capsaicin sensitive afferents,"" Brain Res. 930, 2002, 67-74.;;Spataro et al., ""Spinal gap junctions: potential involvement in pain facilitation,"" J. Pain 5, 2004, 392-405.;;Su et al., ""Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor,"" J. Neurochem. 108, 2009, 1385-1398.;;Takahashi et al., ""Dermatomes in the rat limbs as determined by antidromic stimulation of sensory C-fibers in spinal nerves,"" Pain 67, 1996, 197-202.;;Tan et al., ""Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury,"" J. Neurosci. 28, 2008, 13173-13183.;;Thompson et al., ""Leukemia inhibitory factor induces mechanical allodynia but not thermal hyperalgesia in the juvenile rat,"" Neuroscience 71, 1996, 1091-1094.;;Vierck Jr. et al., ""Pain following spinal cord injury: animal models and mechanistic studies,"" Pain 89, 2000, 1-5.;;Wieseler et al., ""Below Level Central Pain Induced by Discrete Dorsal Spinal Cord Injury,"" Journal of Neurotrauma 27, Sep. 2010, 1697-1707.;;Yezierski, ""Pain following spinal cord injury: central mechanisms,"" Handb. Clin. Neurol. 81, 2006, 293-V.;;Yezierski ""Spinal Cord Injury: A Model of Central Neuropathic Pain,"" Neurosignals, 14, 4, Oct. 2005, 182-193.;;Yezierski et al., ""Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model,"" Pain 75, 1998, 141-155.;;Yokota et al., ""Sympathetic skin response in patients with multiple sclerosis compared with patients with spinal cord transection and normal controls,"" Brain 114, 1991, 1381-1394.;;Zhao et al., ""Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury,"" J. Neurosci. 27, 2007, 2357-2368.;;Zhou et al., ""Differences in c-jun and nNOS expression levels in motoneurons following different kinds of axonal injury in adult rats,"" Brain Cell Biol. 36, 2008, 213-227.;;PCT International Search Report and Written Opinion dated Oct. 6, 2009, PCT/US2009/053915, 25 pages.;;Rodrigues-Filho, Avulsion injury of the rat brachial plexus triggers hyperalgesia and allodynia in the hindpaws: a new model for the study of neuropathic pain, Brain Res. (Aug. 29, 2003), 982(2):186-194.;;Non-Final Office Action dated Mar. 4, 2013, U.S. Appl. No. 13/059,027, 10 pages.;;Australian Office Action dated Apr. 16, 2012, Australian Patent Application No. 2009281824, 2 pages.;;European Search Report dated Jan. 17, 2012, European Patent Application No. 098073778, 10 pages.;;Felipe, et al., ""Excitotoxic injury to the rat spinal cord does not promote sprouting of myelinated fibers to the superficial laminae,"" Database Biosis [online] Biosciences Information Service, Philadelphia, Pennsylvania, 2003, 3 pages.;;Saade, et al., ""The Role of the Dorsal Columns in Neuropathic Behavior: Evidence for Plasticity and Non-Specificity,"" Neuroscience, 2002, vol. 115, No. 2, pp. 403-413.;;Scholz, et al., ""Blocking Caspase Activity Prevents Transsynaptic Neuronal Apoptosis and the Loss of Inhibition in Lamina II of the Dorsal Horn after Peripheral Nerve Injury,"" The Journal of Neuroscience, Aug. 10, 2005, vol. 25, No. 32, pp. 7317-7323.;;Ramer, et al., 2004, The Journal of Neuroscience, 24: 10796-10805.;;Aoki, et al., 2003, Brain Research, 989: 214-220.",ACTIVE
12,EP,B1,EP 3525782 B1,074-767-469-765-296,2023-12-06,2023,EP 17860014 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,,CNS BIOSCIENCES INC,FALCI SCOTT P,,https://lens.org/074-767-469-765-296,Granted Patent,yes,5,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K31/395;;A61P25/00;;A61P29/00;;C07D207/263,,5,0,,,"N B FINNERUP ET AL: ""Levetiracetam in spinal cord injury pain: a randomized controlled trial"", SPINAL CORD, vol. 47, no. 12, 9 June 2009 (2009-06-09), pages 861-867, XP055724716, GB ISSN: 1362-4393, DOI: 10.1038/sc.2009.55;;HOOK, MA ET AL.: 'Intrathecal Morphine Attenuates Recovery of Function after a Spinal Cord Injury' JOURNAL OF NEUROTRAMA May 2009, page 742, XP055476339;;DRYSDALE, DG ET AL.: 'Phantom sensations in people with complete spinal cord lesions: A grounded theory perspective' DISABILITY AND REHABILITATION 2009, page 667, XP055476752;;SIDDALL, PJ ET AL.: 'Classification of pain following spinal cord injury' SPINAL CORD 1997, page 72, XP055476754;;FALCI, SP ET AL.: 'Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome' JOURNAL OF NEUROSURGERY September 2002, page 193, XP008098883",ACTIVE
13,US,B2,US 11596596 B2,083-096-272-813-866,2023-03-07,2023,US 201716341855 A,2017-10-16,US 201716341855 A;;US 201662408490 P;;US 2017/0056745 W,2016-10-14,Treating neuropathic pain in spinal cord injured individuals,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,CNS BIOSCIENCES INC,FALCI SCOTT P,CNS BIOSCIENCES INC (2019-05-06),https://lens.org/083-096-272-813-866,Granted Patent,yes,5,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K9/00;;A61K9/19;;A61P25/00;;A61P29/00,,6,6,019-299-836-642-740;;106-075-441-376-397;;087-843-267-566-970;;013-922-410-051-170;;081-359-493-284-709;;042-613-173-044-999,19506571;;10.1038/sc.2009.55;;11094007;;10.1097/00000539-200012000-00037;;10.1089/neu.2008.0710;;pmc2800819;;19388818;;10.1080/09638280801923607;;18608429;;10.1038/sj.sc.3100365;;9044512;;10.3171/spi.2002.97.2.0193;;12296678,"Finnerup et al. “Levetiracetam in spinal cord injury pain: a randomized controlled trial,” Spinal Cord, 2009, vol. 47, pp. 861-867 (Year: 2009).;;Siddal et al. “The efficacy of intracthecal morphine and clonidine in the treatment of pain after spinal cord injury,” Anesth. Analg. 2000, vol. 91, pp. 1493-1498. (Year: 2000).;;Hook et al.; “Intrathecal Morphine Attenuates Recovery of Function after a Spinal Cord injury”; Journal of Neurotrauma; May 2009; 12 pages.;;Drysdale et al.; “Phantom sensations in people with complete spinal cord lesions: A grounded theory perspective” Disability and Rehabilitation, 2009; 31(4); pp. 267-276.;;Siddall et al.; “Classification of pain following spinal cord Injury”; Spinal Cord (1997) 35: pp. 69-75.;;Falci et al.; “Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome”: Journal of Neurosurgery; Sep. 2002; 9 pages.",ACTIVE
14,US,A1,US 2023/0355508 A1,096-900-281-571-172,2023-11-09,2023,US 202318177018 A,2023-03-01,US 202318177018 A;;US 201916341855 A;;US 2017/0056745 W;;US 201662408490 P,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,CNS BIOSCIENCES INC,FALCI SCOTT P,,https://lens.org/096-900-281-571-172,Patent Application,yes,0,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K9/00;;A61P25/00;;A61P29/00,,0,0,,,,PENDING
15,AU,A1,AU 2003/280063 A1,182-533-449-697-058,2004-01-19,2004,AU 2003/280063 A,2003-06-25,US 39239602 P;;US 23290802 A;;US 0319766 W,2002-06-27,METHOD FOR ERADICATING PAIN OF CENTRAL ORIGIN RESULTING FROM SPINAL CORD INJURY,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/182-533-449-697-058,Patent Application,no,0,0,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04,,0,0,,,,DISCONTINUED
16,US,A1,US 2014/0041065 A1,181-656-479-090-269,2014-02-06,2014,US 201313960465 A,2013-08-06,US 201313960465 A;;US 54175409 A;;US 8897808 P,2008-08-14,Animal Model of Central Neuropathic Pain and Methods of Making and Using the Same,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/181-656-479-090-269,Patent Application,yes,1,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A61K49/00,800/9,0,0,,,,ACTIVE
17,EP,B1,EP 2326165 B1,191-777-739-799-631,2014-04-16,2014,EP 09807377 A,2009-08-14,US 2009/0053915 W;;US 8897808 P,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND METHODS OF MAKING AND USING THE SAME,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/191-777-739-799-631,Granted Patent,yes,2,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00;;G01N33/50,,6,0,,,"YEZIERSKI: ""Spinal Cord Injury: A Model of Central Neuropathic Pain"", NEUROSIGNALS, KARGER, BASEL; CH, vol. 14, no. 4, 1 October 2005 (2005-10-01), pages 182-193, XP008135862, ISSN: 1424-862X, DOI: DOI:10.1159/000087657;;SCHOLZ JOACHIM ET AL: ""Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury"", JOURNAL OF NEUROSCIENCE, vol. 25, no. 32, August 2005 (2005-08), pages 7317-7323, XP002643509, ISSN: 0270-6474;;DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2003, FELIPE I ET AL: ""Excitotoxic injury to the rat spinal cord does not promote sprouting of myelinated fibers to the superficial laminae."", XP002643510, Database accession no. PREV200400146309 & SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, vol. 2003, 2003, pages Abstract No. 814.2 URL-http://sf, 33RD ANNUAL MEETING OF THE SOCIETY OF NEUROSCIENCE; NEW ORLEANS, LA, USA; NOVEMBER 08-12, 2003;;SAADE N E ET AL: ""The role of the dorsal columns in neuropathic behavior: Evidence for plasticity and non-specificity."", NEUROSCIENCE, vol. 115, no. 2, 2 December 2002 (2002-12-02), pages 403-413, XP002643511, ISSN: 0306-4522;;WIESELER JULIE ET AL: ""Below Level Central Pain Induced by Discrete Dorsal Spinal Cord Injury"", JOURNAL OF NEUROTRAUMA, vol. 27, no. 9, September 2010 (2010-09), pages 1697-1707, XP002643512, ISSN: 0897-7151;;YEZIERSKI: 'Spinal Cord Injury: A Model of Central Neuropathic Pain' NEUROSIGNALS vol. 14, no. 4, October 2005, pages 182 - 193, XP008135862",ACTIVE
18,US,A1,US 2010/0203022 A1,015-411-773-102-449,2010-08-12,2010,US 70287310 A,2010-02-09,US 70287310 A;;US 15111609 P,2009-02-09,METHODS AND COMPOSITIONS FOR DELIVERING THERAPEUTIC AGENTS TO THE CENTRAL NERVOUS SYSTEM,Methods are provided for targeting therapeutic agents to an injury site within the central nervous system.,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/015-411-773-102-449,Patent Application,yes,1,2,2,2,0,A61K35/12;;A61B8/0816;;A61P25/00;;A61K35/12;;A61B8/0816,A61K35/12;;A61P25/00,424/93.7,0,0,,,,DISCONTINUED
19,WO,A1,WO 2010/091408 A1,116-434-840-793-619,2010-08-12,2010,US 2010/0023634 W,2010-02-09,US 15111609 P,2009-02-09,METHODS AND COMPOSITIONS FOR DELIVERING THERAPEUTIC AGENTS TO THE CENTRAL NERVOUS SYSTEM,Methods are provided for targeting therapeutic agents to an injury site within the central nervous system.,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/116-434-840-793-619,Patent Application,yes,1,0,2,2,0,A61K35/12;;A61B8/0816;;A61P25/00;;A61K35/12;;A61B8/0816,A01N37/36;;A61K35/12,,2,2,040-102-764-277-164;;001-593-069-642-355,18073518;;10.1159/000112426;;10.1097/01.nrl.0000038587.58012.05;;12801427,"RILEY ET AL.: ""Targeted Spinal Cord Therapeutics Delivery: Stabilized Platform and Microelectrode Recording Guidance Validation in Stereotactic and Functional Neurosurgery"", vol. 86, 2008, pages 67 - 74;;BECKER ET AL.: ""Restoring Function After Spinal Cord Injury"", THE NEUROLOGIST, vol. 9, 2003, pages 1 - 15",PENDING
20,EP,A2,EP 1531897 A2,066-482-134-121-22X,2005-05-25,2005,EP 03742149 A,2003-06-25,US 0319766 W;;US 39239602 P;;US 23290802 A,2002-06-27,METHOD FOR ERADICATING PAIN OF CENTRAL ORIGIN RESULTING FROM SPINAL CORD INJURY,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/066-482-134-121-22X,Patent Application,yes,0,0,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61N1/08;;A61B5/04,,0,0,,,,DISCONTINUED
21,AU,B2,AU 2009/281824 B2,034-314-623-560-844,2014-01-30,2014,AU 2009/281824 A,2009-08-14,US 8897808 P;;US 2009/0053915 W,2008-08-14,Animal model of central neuropathic pain and methods of making and using the same,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/034-314-623-560-844,Granted Patent,no,0,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00,,1,1,007-478-560-973-095,10.1159/000087657;;16215301,"YEZIERSKI, R. P. Neurosignals, 2005, vol. 14, pages 182-193",INACTIVE
22,EP,A1,EP 2326165 A1,105-361-336-604-790,2011-06-01,2011,EP 09807377 A,2009-08-14,US 2009/0053915 W;;US 8897808 P,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND METHODS OF MAKING AND USING THE SAME,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/105-361-336-604-790,Patent Application,yes,0,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00;;G01N33/50,,0,0,,,,ACTIVE
23,AU,A1,AU 2009/281824 A1,141-397-184-684-655,2010-02-18,2010,AU 2009/281824 A,2009-08-14,US 8897808 P;;US 2009/0053915 W,2008-08-14,Animal model of central neuropathic pain and methods of making and using the same,,SCOTT FALCI,FALCI SCOTT P,,https://lens.org/141-397-184-684-655,Patent Application,no,0,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00,,0,0,,,,INACTIVE
24,AU,B2,AU 2017/341927 B2,013-936-249-662-289,2021-12-16,2021,AU 2017/341927 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,Treating neuropathic pain in spinal cord injured individuals,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,CNS BIOSCIENCES INC,FALCI SCOTT P,"CNS BIOSCIENCES, INC. (2019-06-13)",https://lens.org/013-936-249-662-289,Granted Patent,no,3,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,C07D207/263;;A61K31/395;;A61K31/4015;;A61P25/00;;A61P29/00,,1,1,019-299-836-642-740,19506571;;10.1038/sc.2009.55,"SPINAL CORD, 2009, vol. 47, no. 12, pages 861 - 867",ACTIVE
25,EP,A4,EP 2326165 A4,037-477-328-623-641,2012-02-29,2012,EP 09807377 A,2009-08-14,US 2009/0053915 W;;US 8897808 P,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND METHODS OF MAKING AND USING THE SAME,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/037-477-328-623-641,Search Report,no,0,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00;;G01N33/50,,6,4,007-478-560-973-095;;132-011-327-703-964;;015-023-355-776-112;;055-680-742-711-942,10.1159/000087657;;16215301;;10.1523/jneurosci.1526-05.2005;;pmc6725303;;16093381;;10.1016/s0306-4522(02)00417-7;;12421606;;10.1089/neu.2010.1311;;pmc2966849;;20649467,"YEZIERSKI: ""Spinal Cord Injury: A Model of Central Neuropathic Pain"", NEUROSIGNALS, KARGER, BASEL; CH, vol. 14, no. 4, 1 October 2005 (2005-10-01), pages 182 - 193, XP008135862, ISSN: 1424-862X, DOI: 10.1159/000087657;;SCHOLZ JOACHIM ET AL: ""Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury"", JOURNAL OF NEUROSCIENCE, vol. 25, no. 32, August 2005 (2005-08-01), pages 7317 - 7323, XP002643509, ISSN: 0270-6474;;DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2003, FELIPE I ET AL: ""Excitotoxic injury to the rat spinal cord does not promote sprouting of myelinated fibers to the superficial laminae."", XP002643510, Database accession no. PREV200400146309;;SAADE N E ET AL: ""The role of the dorsal columns in neuropathic behavior: Evidence for plasticity and non-specificity."", NEUROSCIENCE, vol. 115, no. 2, 2 December 2002 (2002-12-02), pages 403 - 413, XP002643511, ISSN: 0306-4522;;WIESELER JULIE ET AL: ""Below Level Central Pain Induced by Discrete Dorsal Spinal Cord Injury"", JOURNAL OF NEUROTRAUMA, vol. 27, no. 9, September 2010 (2010-09-01), pages 1697 - 1707, XP002643512, ISSN: 0897-7151;;See also references of WO 2010019901A1",ACTIVE
26,US,A1,US 2007/0016264 A1,084-319-117-571-088,2007-01-18,2007,US 53202806 A,2006-09-14,US 53202806 A;;US 23290802 A;;US 39239602 P,2002-06-27,METHOD FOR ERADICATING PAIN OF CENTRAL ORIGIN RESULTING FROM SPINAL CORD INJURY,"Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/084-319-117-571-088,Patent Application,yes,11,19,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04;;A61N1/00,607/46,2,1,057-808-111-549-160,7897519;;10.3171/jns.1995.82.4.0587,"Falci S, Best L, et al. Surgical Treatment of Spinal Cord Injury (SCI) Pain Using A NewTechnique of Intramedullary Electrical Analysis. Journal of Spinal Cord Medicine.1999; Fall,22:39.;;Fazl et al. Spinal cord mapping with evoked responses for accurate localization of the dorsal root entry zone. J Neurosurg. 1995 82:587-591.",EXPIRED
27,US,A1,US 2011/0229412 A1,017-142-126-192-484,2011-09-22,2011,US 200913059027 A,2009-08-14,US 200913059027 A;;US 8897808 P;;US 2009/0053915 W,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND MEHTODS OF MAKING AND USING THE SAME,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/017-142-126-192-484,Patent Application,yes,4,3,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A61K49/00;;A01K67/00,424/9.2;;800/9,1,1,048-908-164-670-45X,10.1016/s0006-8993(03)03007-5;;12915254,"Rodrigues-Filho et al.,Avulsion injury of the rat brachial plexus triggers hyperalgesia and allodynia in the hindpaws: a new model for the study of neuropathic pain.Brain Res. 2003 Aug 29;982(2):186-94.",DISCONTINUED
28,CA,A1,CA 3040482 A1,069-304-999-701-781,2018-04-19,2018,CA 3040482 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/069-304-999-701-781,Patent Application,no,0,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K31/395;;A61P25/00;;A61P29/00;;C07D207/263,,0,0,,,,PENDING
29,WO,A2,WO 2004/002568 A2,122-587-125-304-630,2004-01-08,2004,US 0319766 W,2003-06-25,US 39239602 P;;US 23290802 A,2002-06-27,METHOD FOR ERADICATING PAIN OF CENTRAL ORIGIN RESULTING FROM SPINAL CORD INJURY,"Methods are provided to reliably identify (110) and surgically eradicate (116) aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/122-587-125-304-630,Patent Application,yes,0,1,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04,,0,0,,,,PENDING
30,US,B2,US 8694107 B2,030-371-186-546-635,2014-04-08,2014,US 53202806 A,2006-09-14,US 53202806 A;;US 23290802 A;;US 39239602 P,2002-06-27,Method for eradicating pain of central origin resulting from spinal cord injury,"Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/030-371-186-546-635,Granted Patent,yes,11,12,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04;;A61N1/18,607/46,60,49,050-827-786-021-97X;;057-808-111-549-160;;009-676-914-696-09X;;043-689-947-194-657;;034-179-804-649-603;;102-900-691-991-204;;054-194-944-604-950;;111-954-598-624-258;;011-339-592-742-691;;004-005-536-543-723;;033-182-080-390-915;;093-789-739-978-854;;050-404-273-241-374;;049-195-529-310-385;;061-013-964-046-085;;077-058-844-932-138;;045-512-160-146-132;;030-078-041-013-376;;042-464-219-707-289;;078-676-565-842-433;;071-711-773-037-486;;063-117-296-772-848;;146-086-629-932-409;;068-924-012-284-272;;007-786-314-603-595;;007-736-069-997-141;;107-525-322-360-159;;028-569-557-818-604;;071-831-190-849-016;;065-000-261-982-056;;119-631-962-944-712;;007-871-832-644-393;;032-145-917-386-792;;016-035-360-844-524;;052-673-967-040-866;;099-057-983-804-674;;006-879-071-891-516;;064-836-925-055-305;;113-001-920-533-224;;135-874-356-576-581;;009-773-696-078-924;;051-037-333-921-019;;024-882-109-495-624;;097-730-007-005-116;;000-738-239-138-804;;021-631-601-628-577;;075-553-981-780-615;;008-114-566-811-184;;042-613-173-044-999,10.1310/uxq1-wn8a-6pa0-8wqt;;7897519;;10.3171/jns.1995.82.4.0587;;15995126;;10.2106/jbjs.d.02840;;10.1016/s0002-9610(32)91133-7;;10.1016/j.pain.2004.08.010;;15494196;;1192653;;11166964;;10.1016/s0304-3959(00)00490-5;;10.1097/00004691-199701000-00003;;9013358;;15393339;;10.3171/jns.1949.6.6.0530;;10.1038/sj.sc.3100737;;9773443;;20270305;;10.1001/archsurg.1947.01230080441005;;3760955;;10.3171/jns.1986.65.4.0465;;10.1093/brain/awh623;;16109750;;20779968;;pmc2457248;;10.1136/bmj.2.3941.112;;10.1126/science.1094925;;15131310;;3389794;;10.1159/000099961;;10.2174/1568010043343804;;15379598;;10.1016/j.expneurol.2005.02.019;;15899262;;10.1159/000100133;;3490223;;15389827;;10.1002/jnr.20274;;15233942;;10.1016/j.ymthe.2004.04.017;;15256650;;10.1126/science.305.5682.326;;10.1016/0304-3959(77)90133-6;;15879185;;10.1126/science.308.5723.778;;15350966;;10.1016/j.nbd.2004.05.010;;448420;;10.3171/jns.1979.51.1.0059;;10.3171/jns.1981.55.3.0414;;6167696;;16219025;;10.1111/j.1471-4159.2005.03462.x;;9521323;;10.1038/32660;;10911921;;10.1111/j.1749-6632.2000.tb06673.x;;15338057;;10.1007/s00018-004-4235-4;;10.1007/bf01420297;;8738385;;9711710;;10.1159/000099917;;10.1016/0304-3959(80)90079-2;;7402693;;10.2174/1568026054367638;;16022678;;10.1152/jn.1997.78.5.2641;;9356413;;10.1097/00004691-199301000-00002;;8458993;;10.1038/sj.sc.3101116;;11402361;;15960884;;10.1111/j.1745-7254.2005.00123.x;;15501197;;10.1016/j.jpain.2004.06.006;;9232750;;10.1038/sj.sc.3100411;;10.1016/s0304-3959(00)00463-2;;11113287;;10.1159/000087655;;16215299;;10.1080/01952307.1986.11719622;;3783152;;10.1093/brain/114.3.1381;;2065256;;10.1016/j.molbrainres.2005.04.013;;15922485;;9121805;;10.1016/s0304-3959(96)03178-8;;11166482;;10.1016/s0304-3959(00)00369-9;;10.3171/spi.2002.97.2.0193;;12296678,"Nashold et al. (""Dorsal Root Entry Zone Lesions: A New Neurosurgical Therapy for Deafferentation Pain"", Advances in Pain Research and Therapy, 1983, vol. 5, pp. 739-750).;;Lammertse et al. ""Surgical Management of Central Pain in Persons with Spinal Cord Injury: The Dorsal Root Entry Zone (DREZ) Procedure,"" Topics in Spinal COrd Injury Rehabilitation. 2001; 7(2), pp. 41-50.;;Falci S, Best L, et al. Surgical Treatment of Spinal Cord Injury (SCI) Pain Using a NewTechnique of Intramedullary Electrical Analysis. Journal of Spinal Cord Medicine.1999; Fall,22:39.;;Fazl et al. Spinal cord mapping with evoked responses for accurate localization of the dorsal root entry zone. J Neurosurg. 1995 82:587-591.;;Alpantaki, et al., ""Sympathetic and Sensory Neural Elements in the Tendon of the Long Head of the Biceps,"" The Journal of Bone and Joint Surgery, Jul. 2005, pp. 1580-1583, vol. 87-A, No. 7.;;Browder, ""Do Sympathetic Nerves Transmit Painful Impulses?"", The American Journal of Surgery, 1932, pp. 100-102, vol. 18, No. 1.;;Cronin, et al., ""Laminar distribution of GABAA- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumbar spinal cord: effects of picrotoxin and strychnine on expression of Fos-like immunoreactivity,"" Pain, Nov. 2004, pp. 156-163, vol. 112.;;Davis, ""Pain and Suffering Following Spinal Cord Injury,"" Clinical Orthopaedics and Related Research, 1975, pp. 76-80, No. 112.;;DeLeo, et al., ""The role of neuroinflammation and neuroimmune activation in persistent pain,"" Pain, 2001, pp. 1-6, vol. 90.;;Deutscher [editor], Methods in Enzymology, 1990, vol. 182: Guide to Protein Purification, Academic Press, Inc.;;Dotson, Clinical Neurophysiology Laboratory Tests to assess the Nociceptive System in Humans, Journal of Clinical Neurophysiology, 1997, pp. 32-45, vol. 14, No. 1.;;Echlin, ""Pain Responses on Stimulation of the Lumbar Sympathetic Chain under Local Anesthesia,"" Journal of Neurosurgery, 1949, pp. 530-533, vol. 6.;;Eide, ""Pathophysiological mechanisms of central neuropathic pain after spinal cord injury,"" Spinal Cord, 1998, pp. 601-612, vol. 36, No. 9.;;Freeman, et al., ""Surgical Relief of Pain in Paraplegic Patients,"" Archives of Surgery, 1947, pp. 433-440, vol. 55.;;Friedman, et al., ""DREZ lesions for relief of pain related to spinal cord injury,"" Journal of Neurosurgery, 1986, pp. 465-469, vol. 65, No. 4.;;Goeddel [editor], Methods in Enzymology, 1990, vol. 185: Gene Expression Technology, Academic Press, Inc.;;Graham, et al., ""Chapter 11: Manipulation of Adenovirus Vectors,"" Methods in Molecular Biology, 1991, pp. 109-128, vol. 7: Gene Transfer and Expression Protocols, The Humana Press Inc., Clifton, New Jersey.;;Hains, et al., ""Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury,"" Brain, 2005, pp. 2359-2371, vol. 128.;;Harris, ""The Role of the Sympathetic in Sensory Conduction and Certain Neuralgias,"" British Medical Journal, 1936, pp. 112-115, vol. 2.;;Harvey, et al., ""GlyR alpha3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization,"" Science, 2004, pp. 884-887, vol. 304.;;Human, ""Research knocks out pain,"" Denver Post, 2005.;;Innis, et al. [editor], PCR Protocols: A Guide to Methods and Applications, 1990, Academic Press, Inc., San Diego, California.;;Ishijima, et al., ""Lesions of Spinal and Trigeminal Dorsal Root Entry Zone for Deafferentation Pain,"" Applied Neurophysiology, 1988, pp. 175-187, vol. 51, No. 2-5.;;Ji, ""Peripheral and Central Mechanisms of Inflammatory Pain, with Emphasis on MAP Kinases,"" Current Drug Targets-Inflammation & Allergy, 2004, pp. 299-303, vol. 3, No. 3.;;Jongen, et al., ""Intrathecal injection of GDNF and BDNF induces immediate early gene expression in rat spinal dorsal horn,"" Experimental Neurology, Jul. 2005, pp. 255-266, vol. 194, No. 1.;;Katims, et al. ""Transcutaneous Nerve Stimulation,"" Applied Neurophysiology, 1986, pp. 86-91, vol. 49, No. 1-2.;;Li, et al., ""Alterations in Spinal Cord Gene Expression After Hindpaw Formalin Injection,"" Journal of Neuroscience Research, 2004, pp. 533-541, vol. 78.;;Liu, et al., ""Peripherally Delivered Glutamic Acid Decarboxylase Gene Therapy for Spinal Cord Injury Pain,"" Molecular Therapy, 2004 pp. 57-66, vol. 10, No. 1.;;Marx, ""Prolonging the Agony,"" Science, 2004, p. 326-329, vol. 305.;;Melzack, et al., ""Phantom Body Pain in Paraplegics: Evidence for a Central 'Pattern Generating Mechanism' for Pain,"" Pain, 1978, pp. 195-210, vol. 4.;;Miller, ""The Dark Side of Glia,"" Science, 2005, pp. 778-781, vol. 308.;;Morales-Aza, et al., ""Inflammation alters cation chloride cotransporter expression in sensory neurons,"" Neurobiology of Disease, 2004, pp. 62-69, vol. 17.;;Nashold Jr., et al., ""Dorsal root entry zone lesions for pain relief,"" Journal of Neurosurgery, 1979, pp. 59-69, vol. 51, Nos. 1-6.;;Nashold Jr., et al., ""Dorsal root entry zone lesions to control central pain in paraplegics,"" Journal of Neurosurgery, 1981, pp. 414-419, vol. 55, Nos. 1-6.;;Nashold Jr., et al., ""Dorsal Root Entry Zone Lesions: A New Neurosurgical Therapy for Deafferentation Pain,"" Advances in Pain Research and Therapy, 1983, pp. 739-750, vol. 5.;;Nesic, et al., ""Transcriptional profiling of spinal cord injury-induced central neuropathic pain,"" Journal of Neurochemistry, 2005, pp. 998-1014, vol. 95.;;Okuda-Ashitaka, et al., ""Nocistatin, a peptide that blocks nociceptin action in pain transmission,"" Nature, 1998, pp. 286-289, vol. 392, No. 6673.;;Ossipov, et al., ""Spinal and Supraspinal Mechanisms of Neuropathic Pain,"" Annals of the New York Academy of Sciences, 2000, pp. 12-24, vol. 909.;;Patte-Mensah, et al., ""Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks,"" Cellular and Molecular Life Sciences, Sep. 2004, pp. 2274-2284, vol. 61, No. 17.;;Pick, The Autonomic Nervous System, 1970, J.B. Lippincott Company, U.S.;;Rath, et al., ""Results of DREZ Coagulations for Pain Related to Plexus Lesions, Spinal Cord Injuries and Postherpetic Neuralgia,"" Acta Neurochirurgica, 1996, pp. 364-369, vol. 138, No. 4.;;Rath, et al., ""DREZ Coagulations for Deafferentation Pain Related to Spinal and Peripheral Nerve Lesions: Indication and Results of 79 Consecutive Procedures,"" Stereotactic and Functional Neurosurgery, 1997, pp. 161-167, vol. 68.;;Richards, et al., ""Psycho-Social Aspects of Chronic Pain in Spinal Cord Injury,"" Pain, 1980, pp. 355-366, vol. 8.;;Salter, ""Cellular Signalling Pathways of Spinal Pain Neuroplasticity as Targets for Analgesic Development,"" Current Topics in Medicinal Chemistry, 2005, pp. 557-567, vol. 5, No. 6.;;Sambrook, et al., Molecular Cloning, 1989, Cold Spring Harbor Laboratory Press, U.S.;;Schmidt, et al., ""Innervation Territories of Mechanically Activated C Nociceptor Units in Human Skin,"" Journal of Neurophysiology, 1997, pp. 2641-2648, vol. 78, No. 5.;;Shields, ""Functional Anatomy of the Autonomic Nervous System,"" Journal of Clinical Neurophysiology, 1993, pp. 2-13, vol. 10, No. 1.;;Siddall, et al., ""Pain following spinal cord injury,"" Spinal Cord, 2001, pp. 63-73, vol. 39, No. 2.;;Song, et al., ""Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats,"" Acta Pharmacologica Sinica, Jul. 2005, pp. 789-798, vol. 26, No. 7.;;Spataro, et al., ""Spinal Gap Junctions: Potential involvement in Pain Facilitation,"" The Journal of Pain, Sep. 2004, pp. 392-405, vol. 5, No. 7.;;Störmer, et al., ""Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study,"" Spinal Cord, 1997, pp. 446-455, vol. 35, No. 7.;;Vierck Jr., et al., ""Pain following spinal cord injury: animal models and mechanistic studies,"" Pain, 2000, pp. 1-5, vol. 89.;;Wieseler-Frank, et al., ""Central Proinflammatory Cytokines and Pain Enhancement,"" Neurosignals, 2005, pp. 166-174, vol. 14.;;Woolsey, ""Chronic Pain Following Spinal Cord Injury,"" The Journal of the American Paraplegia Society, 1986, pp. 39-41, vol. 9.;;Yokota, et al., ""Sympathetic Skin Response in Patients with Multiple Sclerosis Compared with Patients with Spinal Cord Transection and Normal Controls,"" Brain, 1991, pp. 1381-1394, vol. 114, No. 3.;;Yu, et al., ""Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury,"" Molecular Brain Research, 2005, pp. 244-255, vol. 138.;;Yezierski, ""Pain following spinal cord injury: the clinical problem and experimental studies,"" Pain, 1996, pp. 185-194, vol. 68, Nos. 2-3.;;Defrin, et al., ""Characterization of chronic pain and somatosensory function in spinal cord injury subjects,"" PAIN, vol. 89, 2001, pp. 253-163.;;Falci, et al., ""Dorsal root entry zone microcoagulation for spinal cord injury-related central pain: operative intramedullary electrophysiological guidance and clinical outcome,"" J. Neurosurg: Spine, vol. 97, 2002, pp. 193-200.;;European Search Report, Appl. No. EP 03742149.2, Dec. 3, 2008, 6 pages.",ACTIVE
31,US,A1,US 2010/0040551 A1,053-692-380-561-363,2010-02-18,2010,US 54175409 A,2009-08-14,US 54175409 A;;US 8897808 P,2008-08-14,Animal Model of Central Neuropathic Pain and Methods of Making and Using the Same,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/053-692-380-561-363,Patent Application,yes,3,2,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A61K49/00;;A01K67/00;;C07D471/02,424/9.2;;800/9;;546/121,0,0,,,,INACTIVE
32,DK,T3,DK 2326165 T3,066-885-957-685-559,2014-07-21,2014,DK 09807377 T,2009-08-14,US 8897808 P;;US 2009/0053915 W,2008-08-14,DYREMODEL AF CENTRALE NEUROPATISKE SMERTER OG FREMGANGSMÅDER TIL FREMSTILLING OG ANVENDELSE DERAF,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/066-885-957-685-559,Granted Patent,no,0,0,14,14,0,A61K49/0008;;A61K49/0008;;A01K67/027;;A01K67/027;;A01K2207/30;;A01K2207/30;;A01K2227/105;;A01K2227/105;;A01K2267/0393;;A01K2267/0393;;A61K9/0085;;G01N33/5088;;G01N33/5088,A01K67/00;;A01K67/033;;A01N1/00;;G01N33/50,,0,0,,,,ACTIVE
33,WO,A1,WO 2019/079327 A1,178-371-238-302-040,2019-04-25,2019,US 2018/0056121 W,2018-10-16,US 201762572833 P,2017-10-16,COMBINATION THERAPIES AND OPIOID ADDICTION TREATMENT BY ADMINISTERING BRIVARACETAM OR LEVETIRACETAM AND AN OPIOID,"Disclosed herein are methods of methods of treating pain in a subject, reducing opioid dose without increasing pain to a subject, and decreasing pain in a subject without decreasing an opioid dose.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/178-371-238-302-040,Patent Application,yes,1,0,1,1,0,A61K31/4015;;A61K31/135;;A61K31/4468;;A61K31/485,A61K31/485;;A61K31/4015;;A61K31/4468;;C07D207/263;;C07D207/27;;C07D489/02;;C07D489/04,,1,1,082-862-943-535-371,15814513;;10.1300/j354v19n01_07;;10.1080/j354v19n01_07,"DUNTEMAN, ED: ""Levetiracetam as an Adjunctive Analgesic in Neoplastic Plexopathies: Case Series and Commentary"", J PAIN PALLIAT CARE PHARMACOTHER., vol. 19, no. 1, 2005, pages 35 - 43, XP008095810, DOI: doi:10.1300/U354v19n01_07",PENDING
34,AU,A8,AU 2003/280063 A8,185-120-937-196-547,2004-01-19,2004,AU 2003/280063 A,2003-06-25,US 39239602 P;;US 23290802 A;;US 0319766 W,2002-06-27,Method for eradicating pain of central origin resulting from spinal cord injury,,FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/185-120-937-196-547,Patent Application,no,0,0,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04,,0,0,,,,DISCONTINUED
35,EP,A4,EP 3525782 A4,022-206-429-273-303,2020-10-07,2020,EP 17860014 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,,CNS BIOSCIENCES INC,FALCI SCOTT P,,https://lens.org/022-206-429-273-303,Search Report,no,3,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K31/395;;A61P25/00;;A61P29/00;;C07D207/263,,2,1,019-299-836-642-740,19506571;;10.1038/sc.2009.55,"N B FINNERUP ET AL: ""Levetiracetam in spinal cord injury pain: a randomized controlled trial"", SPINAL CORD, vol. 47, no. 12, 9 June 2009 (2009-06-09), GB, pages 861 - 867, XP055724716, ISSN: 1362-4393, DOI: 10.1038/sc.2009.55;;See also references of WO 2018071893A1",ACTIVE
36,EP,A1,EP 3525782 A1,057-653-560-742-392,2019-08-21,2019,EP 17860014 A,2017-10-16,US 201662408490 P;;US 2017/0056745 W,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,,CNS BIOSCIENCES INC,FALCI SCOTT P,,https://lens.org/057-653-560-742-392,Patent Application,yes,0,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61K31/4015;;A61K31/395;;A61P25/00;;A61P29/00;;C07D207/263,,0,0,,,,ACTIVE
37,WO,A3,WO 2004/002568 A3,107-439-675-978-690,2004-03-04,2004,US 0319766 W,2003-06-25,US 39239602 P;;US 23290802 A,2002-06-27,METHOD FOR ERADICATING PAIN OF CENTRAL ORIGIN RESULTING FROM SPINAL CORD INJURY,"Methods are provided to reliably identify (110) and surgically eradicate (116) aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/107-439-675-978-690,Search Report,yes,2,0,10,10,0,A61B5/4824;;A61B5/407;;A61B5/24;;A61B5/4824;;A61B5/407;;A61B5/24,A61B5/04,,0,0,,,,PENDING
38,WO,A1,WO 2010/019901 A1,172-451-806-060-011,2010-02-18,2010,US 2009/0053915 W,2009-08-14,US 8897808 P,2008-08-14,ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND METHODS OF MAKING AND USING THE SAME,"The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.",FALCI SCOTT P,FALCI SCOTT P,,https://lens.org/172-451-806-060-011,Patent Application,yes,2,0,14,14,0,A01K67/027;;A01K2207/30;;A01K2227/105;;A01K2267/0393;;G01N33/5088;;A61K49/0008;;A61K9/0085;;A01K67/027;;A01K2207/30;;A01K2227/105;;A01K2267/0393;;G01N33/5088;;A61K49/0008,A01K67/033;;A01K67/00;;A01N1/00,,1,1,007-478-560-973-095,10.1159/000087657;;16215301,"YEZIERSKI: ""Spinal Cord Injury: A Model of Central Neuropathic Pain"", NEUROSIGNALS, vol. 14, no. 4, October 2005 (2005-10-01), pages 182 - 193, XP008135862",PENDING
39,US,A1,US 2019/0321659 A1,166-990-509-294-773,2019-10-24,2019,US 201716341855 A,2017-10-16,US 201716341855 A;;US 201662408490 P;;US 2017/0056745 W,2016-10-14,TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS,Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.,FALCI SCOTT P,FALCI SCOTT P,CNS BIOSCIENCES INC (2019-05-06),https://lens.org/166-990-509-294-773,Patent Application,yes,2,0,13,13,0,A61K31/4015;;A61P25/00;;A61P29/00;;A61P25/00;;A61P29/00;;A61K9/0019;;A61K9/0085;;A61K31/4015,A61P25/00;;A61K9/00;;A61P29/00,,2,2,019-299-836-642-740;;106-075-441-376-397,19506571;;10.1038/sc.2009.55;;11094007;;10.1097/00000539-200012000-00037,"Finnerup Levetiracetam in spinal cord injury pain a randomized controlled trial, Spinal Cord, 2009, Vol. 47, pp 861-867;;Siddal et al The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury, Anesth. Analg. 2000, Vol. 91, pp 1493-1498",ACTIVE
40,US,A,US 4221819 A,081-910-359-277-921,1980-09-09,1980,US 3361179 A,1979-04-26,US 3361179 A,1979-04-26,Water and color retention treatment for frozen processed shrimp,"In a process for treating shrimp that comprises (a) soaking whole, peeled and deveined shrimp in an aqueous solution containing at least one phosphate salt; and (b) thereafter freezing said soaked shrimp to preserve the shrimp for later cooking and consumption; wherein the improvement comprises carrying out sait soaking step for sufficient time and in the presence of an effective amount of a trace metal salt selected from the group consisting of calcium salts, magnesium salts, and mixtures thereof, in order to substantially maintain the trace metal content in said shrimp, whereby said treated shrimp will have white tissue coloration and a natural tender texture after cooking.",OLIN CORP,FALCI KENNETH J;;SCOTT ROBERT N,,https://lens.org/081-910-359-277-921,Granted Patent,yes,4,14,1,1,0,A22C29/02;;A22C29/02;;A23B4/08;;A23B4/08,A22C29/02;;A23B4/08,426/262,4,0,,,"Gordon, A., Journal of Food Manufacturing, Jul. 1971, pp. 57, 58.;;Mathgn, C., Fishery Technology, 5, 1968, pp. 104-112.;;Ellinger, R. H., ""Phosphates as Food Ingredients"", CRC Press, pp. 131-145, 1972.;;Gibson, D. M. et al., Journal of Food Technology, 8, 1973, pp. 197-204.",EXPIRED
